References
- Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Current Medical Literature – Diabetes, 54, 1615–1625. doi:10.2337/diabetes.54.6.1615
- Frankel, E. N., & Finley, J. W. (2008). How to standardize the multiplicity of methods to evaluate natural antioxidants. Journal of Agricultural and Food Chemistry, 56, 4901–4908. doi:10.1021/jf800336p
- Gadang, V., Gilbert, W., Hettiararchchy, N., Horax, R., Katwa, L., & Devareddy, L. (2011). Dietary bitter melon seed increases peroxisome proliferator-activated receptor-γ gene expression in adipose tissue, down-regulates the nuclear factor-κB expression, and alleviates the symptoms associated with metabolic syndrome. Journal of Medicinal Food, 14, 86–93. doi:10.1089/jmf.2010.0010
- Gifford, S. M., Grummer, M. A., Pierre, S. A., Austin, J. L., Zheng, J., & Bird, I. M. (2004). Functional characterization of HUVEC-CS: Ca2+ signaling, ERK 1/2 activation, mitogenesis and vasodilator production. Journal of Endocrinology, 182, 485–499. doi:10.1677/joe.0.1820485
- Grover, J. K., & Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: A review. Journal of Ethnopharmacology, 93, 123–132. 10.1016/j.jep.2004.03.035
- Grover, J. K., Yadav, S. P., & Vats, V. (2002). Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology, 81, 81–100. doi:10.1016/S0378-8741(02)00059-4
- Gutteridge, J. M. C., & Halliwell, B. (1996). Antioxidants in nutrition, health and disease. New York, NY: Oxford University Press.
- Hail, N., Cortes, M., Drake, E. N., & Spallholz, J. E. (2008). Cancer chemoprevention: A radical perspective. Free Radical Biology and Medicine, 45, 97–110. doi:10.1016/j.freeradbiomed.2008.04.004
- Iwashita, K., Kobori, M., Yamaki, K., & Tsushida, T. (2000). Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Bioscience Biotechnology Biochemistry, 64, 1813–1820. doi:10.1271/bbb.64.1813
- Jiratchariyakul, W., Wiwat, C., & Vongsakul, M., Somanabandhu A., Leelamanit W., Fujii I. …, Ebizuka, Y. (2001). HIV inhibitor from Thai bitter gourd. Planta Medica, 67, 350–353. doi:10.1055/s-2001-14323
- Kenny, O., Smyth, T. J., Hewage, C. M., & Brunton, N. P. (2013). Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit. Food Chemistry, 141, 4295–4302. doi:10.1016/j.foodchem.2013.07.016
- Krawinkel, M. B., & Keding, G. B. (2006). Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutrition Reviews, 64, 331–337. doi:10.1111/j.1753-4887.2006.tb00217.x
- Lim, T. K. (2013). Edible medicinal and non-medicinal plants. Dordrecht, the Netherlands: Springer.
- Moon, J. K., & Shibamoto, T. (2009). Antioxidant assays for plant and food components. Journal of Agricultural and Food Chemistry, 57, 1655–1666. doi:10.1021/jf803537k
- Pelicano, H., Carney, D., & Huang, P. (2004). ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates, 7, 97–110. doi:10.1016/j.drup.2004.01.004
- Semiz, A., & Sen, A. (2007). Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. African Journal of Biotechnology, 6, 273–277.
- Talukder, M. D. U., Aklima, J., Emran, T. B., Islam, S., Rahman, A., & Bhuiyan, R. H. (2013). In vitro antioxidant potential of Momordica charantia fruit extracts. British Journal of Pharmaceutical Research, 3, 963–971.
- Visarata, N., & Ungsurungsie, M. (1981). Extracts from Momordica charantia L. Pharmaceutical Biology, 19, 75–80. doi:10.3109/13880208109070580